A Two-part Placebo-controlled Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of BVS857 in Patients With Spinal and Bulbar Muscular Atrophy (SBMA)
Latest Information Update: 03 Oct 2021
At a glance
Most Recent Events
- 28 Apr 2017 Results assessing safety,tolerability and preliminary efficacy of BVS857 presented at the 69th Annual Meeting of the American Academy of Neurology.
- 12 Jul 2016 Status changed from active, no longer recruiting to completed.
- 05 May 2016 Status changed from recruiting to active, no longer recruiting.